163 related articles for article (PubMed ID: 18709327)
1. Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.
Wojtkiewicz A; Wysocki M; Fortuna J; Chrupek M; Matczuk M; Koltan A
Acta Derm Venereol; 2008; 88(4):420-1. PubMed ID: 18709327
[No Abstract] [Full Text] [Related]
2. Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases.
Meiss F; Helmbold P; Meykadeh N; Gaber G; Marsch WCh; Fischer M
J Eur Acad Dermatol Venereol; 2007 May; 21(5):717-9. PubMed ID: 17448012
[No Abstract] [Full Text] [Related]
3. Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab.
Al-Shouli S; Abouchala N; Bogusz MJ; Al Tufail M; Thestrup-Pedersen K
Acta Derm Venereol; 2005; 85(6):534-5. PubMed ID: 16396808
[No Abstract] [Full Text] [Related]
4. Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment.
Hunger RE; Hunziker T; Buettiker U; Braathen LR; Yawalkar N
J Allergy Clin Immunol; 2005 Oct; 116(4):923-4. PubMed ID: 16210071
[No Abstract] [Full Text] [Related]
5. Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis.
Fischer M; Fiedler E; Marsch WC; Wohlrab J
Br J Dermatol; 2002 Apr; 146(4):707-9. PubMed ID: 11966713
[No Abstract] [Full Text] [Related]
6. Successful treatment of childhood cutaneous polyarteritis nodosa with infliximab.
Vega Gutierrez J; Rodriguez Prieto MA; Garcia Ruiz JM
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):570-1. PubMed ID: 17374009
[No Abstract] [Full Text] [Related]
7. Severe cutaneous adverse reactions to drugs.
Chia FL; Leong KP
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
[TBL] [Abstract][Full Text] [Related]
8. Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab.
Jacobi A; Shuler G; Hertl M
Br J Dermatol; 2005 Aug; 153(2):448-9. PubMed ID: 16086769
[No Abstract] [Full Text] [Related]
9. Treatment of toxic epidermal necrolysis with the combination of infliximab and high-dose intravenous immunoglobulin.
Gaitanis G; Spyridonos P; Patmanidis K; Koulouras V; Nakos G; Tzaphlidou M; Bassukas ID
Dermatology; 2012; 224(2):134-9. PubMed ID: 22572593
[TBL] [Abstract][Full Text] [Related]
10. Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis.
Takahashi MD; Castro LG; Romiti R
Br J Dermatol; 2007 Oct; 157(4):828-31. PubMed ID: 17711530
[No Abstract] [Full Text] [Related]
11. [Up-date on the use of infliximab in dermatology. Introduction].
Sánchez-Carazo J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
[No Abstract] [Full Text] [Related]
12. Infliximab in the management of severe pemphigus vulgaris.
Pardo J; Mercader P; Mahiques L; Sanchez-Carazo JL; Oliver V; Fortea JM
Br J Dermatol; 2005 Jul; 153(1):222-3. PubMed ID: 16029365
[No Abstract] [Full Text] [Related]
13. Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus.
Worsnop F; Wee J; Natkunarajah J; Moosa Y; Marsden R
Clin Exp Dermatol; 2012 Dec; 37(8):879-81. PubMed ID: 22548502
[TBL] [Abstract][Full Text] [Related]
14. Infliximab in a patient with refractory mucosal aphthosis.
Jacobi A; Debus D; Schuler G; Hertl M
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):109-10. PubMed ID: 18181985
[No Abstract] [Full Text] [Related]
15. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab.
Brunasso AM; Massone C
Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830
[No Abstract] [Full Text] [Related]
16. [Infliximab].
Herrera E; Habicheyn S
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
[TBL] [Abstract][Full Text] [Related]
17. Perifolliculitis capitis abscedens et suffodiens successfully controlled with infliximab.
Brandt HR; Malheiros AP; Teixeira MG; Machado MC
Br J Dermatol; 2008 Aug; 159(2):506-7. PubMed ID: 18547307
[No Abstract] [Full Text] [Related]
18. Toxic epidermal necrolysis successfully treated with infliximab.
Zárate-Correa LC; Carrillo-Gómez DC; Ramírez-Escobar AF; Serrano-Reyes C
J Investig Allergol Clin Immunol; 2013; 23(1):61-3. PubMed ID: 23653980
[No Abstract] [Full Text] [Related]
19. Treatment of recalcitrant generalized morphea with infliximab.
Diab M; Coloe JR; Magro C; Bechtel MA
Arch Dermatol; 2010 Jun; 146(6):601-4. PubMed ID: 20566921
[No Abstract] [Full Text] [Related]
20. Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab.
Lu R; George SJ; Hsu S
Dermatol Online J; 2006 May; 12(4):18. PubMed ID: 17083873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
